French Medtech Reimbursement - How Added Value And Clinical Benefit Sway Decisions

 
• By Eliza Slawther

In France, many medical devices require value assessments prior to securing market access, a process that manufacturers may find complex. Hubert Galmiche, head of medical device assessment at the French National Authority for Health (HAS) explains what the outcomes of these appraisals mean for companies.

Flag of France in a mixed stack of european coins and a blue background
Source: Shutterstock

The HAS is an independent public scientific advisory body that, among its other responsibilities, makes recommendations for the national reimbursement listing of certain medical devices in France.

Within the HAS, there is a committee known as the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) which makes recommendations to the Ministry of Health on whether a device should

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography